Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP and Prox BTK-Lesions (JETART)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT06434779

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as a collaborator
  • ID3 Medical Registry lists this organization as a collaborator
Registry
  • NCT NCT06434779
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06434779. Allocation not applicable; no masking; primary purpose treatment. Start 2024-07 (anticipated); primary completion 2026-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP and Prox BTK-Lesions (JETART)
Acronym
JETART
Condition
Peripheral Arterial Disease
Intervention (Device)
JETi 6F and 8F Thrombectomy system
Lead sponsor
Vascular Science LP GmbH (class: other)
Collaborator
ID3 Medical (class: other)
Collaborator
Abbott (class: industry)

Record details

Record id
cardio:ct-nct06434779
Content hash
f126cc4c5f5d63785fdd9a179f66acd58fcd6a0d310f86b4d9fc890f15346600